Today's Insider Trading Highlights — August 06, 2026
📅 Published: August 06, 2026 at 12:06 PM UTC
5 Cluster Buys5 Insider Purchases
On August 06, 2026, we detected 5 new cluster buys including a $9.3M purchase in $BSX by 3 insiders, and 5 notable insider purchases. Harrison Street Real Assets Fund LLC (10% Owner) bought $10.0M of $NFRX. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — August 06, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
$47.74
Current Price
52W: $42.20 – $109.50
$100.65
Fair Value
Participants 3 insiders | Total Shares 192,422 | Total Value $9,285,694 |
Timeframe 4 days | Date Range Jul 31, 2026 – Aug 04, 2026 |
👥 Participant Details
P&L: +5.0% (+$11,301) |
P&L: -0.7% ($339) | ||||
P&L: -1.2% ($110,310) |
P&L: -1.7% ($119) |
📊 Valuation & Analyst Info
Fair Value: $100.65 (+110.8% undervalued vs current price)
P/E Ratio: 48.6 (0.9x above Medical - Devices avg (25.2)) (1.1x above Healthcare avg (22.8))
Analyst Consensus: Buy
Price Target: $68.67 (Low: $50.00 | High: $112.00 | Median: $65.00)
$26.51
Current Price
52W: $16.00 – $29.15
Participants 2 insiders | Total Shares 325,000 | Total Value $5,200,000 |
Timeframe 0 days | Date Range Aug 03, 2026 – Aug 03, 2026 |
👥 Participant Details
P&L: +65.7% (+$131,375) |
P&L: +65.7% (+$3,284,375) |
$25.81
Current Price
52W: $23.58 – $28.75
$38.66
Fair Value
Participants 2 insiders | Total Shares 76,863 | Total Value $1,959,190 |
Timeframe 0 days | Date Range Aug 05, 2026 – Aug 05, 2026 |
👥 Participant Details
P&L: +1.1% (+$10,913) |
P&L: +1.4% (+$13,731) |
📊 Valuation & Analyst Info
Fair Value: $38.66 (+49.8% undervalued vs current price)
P/E Ratio: 18.3 (0.8x above Drug Manufacturers - General avg (10.4)) (0.2x below Healthcare avg (22.8))
Analyst Consensus: Hold
Price Target: $26.88 (Low: $25.00 | High: $30.00 | Median: $27.00)
$20.39
Current Price
52W: $19.63 – $42.23
$87.13
Fair Value
Participants 4 insiders | Total Shares 56,463 | Total Value $1,217,199 |
Timeframe 1 days | Date Range Aug 03, 2026 – Aug 04, 2026 |
👥 Participant Details
P&L: -6.3% ($8,609) |
P&L: -6.3% ($17,587) | ||||
P&L: -5.2% ($10,264) |
P&L: -5.1% ($11,071) | ||||
P&L: -5.3% ($4,925) |
P&L: -5.3% ($10,062) | ||||
P&L: -3.2% ($3,400) |
📊 Valuation & Analyst Info
Fair Value: $87.13 (+327.3% undervalued vs current price)
P/E Ratio: 23.2 (0.7x above Banks - Regional avg (13.8)) (0.1x above Financial Services avg (21.2))
Analyst Consensus: Buy
Price Target: $35.00 (Low: $35.00 | High: $35.00 | Median: $35.00)
$33.41
Current Price
52W: $28.36 – $62.89
$38.77
Fair Value
Participants 3 insiders | Total Shares 20,310 | Total Value $652,394 |
Timeframe 1 days | Date Range Aug 03, 2026 – Aug 04, 2026 |
👥 Participant Details
P&L: +5.0% (+$4,977) |
P&L: +4.7% (+$4,009) | ||||
P&L: +3.0% (+$1,513) |
P&L: +3.8% (+$15,663) |
📊 Valuation & Analyst Info
Fair Value: $38.77 (+16.1% undervalued vs current price)
P/E Ratio: 24.8 (0.2x below Specialty Retail avg (31.7)) (0.6x below Consumer Cyclical avg (65.5))
Analyst Consensus: Hold
Price Target: $37.00 (Low: $28.00 | High: $51.00 | Median: $38.00)
💰 Individual Insider Buys
$26.56
Current Price
52W: $25.00 – $27.81
Transaction Date Aug 04, 2026 | Shares 372,856 | Purchase Price $26.82 |
Purchase Value $9,999,998 |
P&L: -1.0% ($95,936)
$47.74
Current Price
52W: $42.20 – $109.50
$100.65
Fair Value
Transaction Date Aug 03, 2026 | Shares 186,240 | Purchase Price $48.33 |
Purchase Value $9,001,408 |
P&L: -1.2% ($110,310)
📊 Valuation & Analyst Info
Fair Value: $100.65 (+110.8% undervalued vs current price)
P/E Ratio: 48.6 (0.9x above Medical - Devices avg (25.2)) (1.1x above Healthcare avg (22.8))
Analyst Consensus: Buy
Price Target: $68.67 (Low: $50.00 | High: $112.00 | Median: $65.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-10-28
$26.51
Current Price
52W: $16.00 – $29.15
Transaction Date Aug 03, 2026 | Shares 312,500 | Purchase Price $16.00 |
Purchase Value $5,000,000 |
P&L: +65.7% (+$3,284,375)
$10.45
Current Price
52W: $10.30 – $10.55
Transaction Date Aug 03, 2026 | Shares 350,000 | Purchase Price $10.00 |
Purchase Value $3,500,000 |
P&L: +4.5% (+$157,500)
$30.21
Current Price
52W: $25.89 – $97.12
$24.74
Fair Value
Transaction Date Aug 04, 2026 | Shares 83,300 | Purchase Price $29.89 |
Purchase Value $2,489,837 |
P&L: +1.1% (+$26,656)
📊 Valuation & Analyst Info
Fair Value: $24.74 (-18.1% overvalued vs current price)
P/E Ratio: 4002.4 (230.4x above Real Estate - Services avg (17.3)) (157.7x above Real Estate avg (25.2))
Analyst Consensus: Buy
Price Target: $40.10 (Low: $26.00 | High: $67.00 | Median: $40.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-10-27
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.
📚 Deep Dive Resources
Data sourced from SEC filings. This is for informational purposes only.
Want to receive these newsletters in your inbox? Sign up here